← Open Payments lookup

LISA CEBRUN MCCRAY: Open Payments

NPI 1740661719 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$487 in 9 payments from 8 companies in 2025. Trend: 2023 $138 · 2024 $604 · 2025 $487

Food & beverage: $392Education: $95
CompanyPaymentsAmount
Astellas Pharma US Inc2$129
JAZZ PHARMACEUTICALS INC.1$107
SANOFI-AVENTIS U.S. LLC1$102
Syndax Pharmaceuticals, Inc.1$33
Janssen Biotech, Inc.1$33
Incyte Corporation1$29
Takeda Pharmaceuticals U.S.A., Inc.1$29
Gamida Cell Inc.1$24

Products named: RYLAZE, REZUROCK, Cresemba, DARZALEX, NIKTIMVO, LIVTENCITY, OMISIRGE.

Industry payments across TX — which companies pay providers there.